세계의 외용약 시장 - 규모, 점유율, 동향 분석 보고서 : 투여 경로별, 유형별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), By Type (Semi-solid, Transdermal), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,242,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,398,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

외용약 시장의 성장과 동향

Grand View Research Inc.의 최신 보고서에 따르면 세계 외용약 시장 규모는 2030년까지 2,693억 달러에 이를 전망입니다.

이 산업은 2025-2030년 중에 CAGR 6.0%를 나타낼 것으로 예측됩니다. 산업 성장에 기여하는 주요 요인은 주요 기업 간의 전략적 제휴와 함께 피부 질환의 유병률 증가를 포함합니다. 건선, 아토피 피부염, 습진과 같은 피부 감염의 유병률 증가는 눈과 귀 치료에 대한 수요가 증가함에 따라 예측 기간 동안 경피 또는 경피 의약품에 대한 수요를 촉진할 것으로 예상됩니다. 예를 들어, 2021년 10월, AbbVie Inc.는 노안 치료용 피로카르핀 염산염 점안액 Vuity의 FDA 승인을 받았습니다.

또한 NCBI에 따르면 건선의 유병률은 유럽에서는 거의 1.92%, 북미에서는 1.5%입니다. 피부질환을 치료하는 외용약의 발매도 피부약 수요를 촉진할 것으로 예상되고 있습니다. 예를 들어, 2020년 9월, 캐나다 Bausch Health는 건선 환자를 위한 새로운 항건선제 Duobrii 로션을 출시했습니다. 기술의 진보와 Alcon, Inc. 및 Novartis AG 등 주요 기업 간의 인수합병 활동 활성화는 산업의 성장을 뒷받침할 것으로 예상되고 있습니다. 예를 들어, 2022년 6월, Novartis AG는 Kedalion Therapeutics를 인수하여 안과용 의약품의 정확한 경피 전달을 촉진하는 AcuStream 기술을 획득했습니다.

게다가 2022년 5월에는 Alcon Inc.가 Kala Pharmaceuticals, Inc.로부터 안과외용약인 Eysuvis(로테프레드놀에타본산 현탁액)를 인수하여 안구건조증 치료의 기존 포트폴리오에 추가했습니다. 예를 들어 WHO에 따르면 전 세계적으로 연간 1,100만 건의 화상이 발생하고 있으며, 그 중 약 18만 건이 사망하고 있다고 합니다. 화상의 치료에는 술파다이아진 크림, 비스무트 함침 석유 거즈, 질산세륨, 아세트산마페나이드, 나노결정 은 등 다양한 외용제가 사용됩니다.

외용약 시장 보고서 하이라이트

• 약물 전달이 시장을 독점했으며 2024년에는 54.1%의 점유율을 차지했습니다.
• 반고형 제제는 2024년 매출 점유율 61.9%로 시장을 선도했습니다.
• 병원 클리닉은 2024년 38.9%로 최대 판매 점유율을 차지했습니다. 이는 전문적인 개입이 필요한 피부질환과 만성질환의 유병률 증가로 인한 것입니다.
• 북미의 외용약 시장은 피부질환의 높은 유병률, 첨단 의료 인프라, 연구개발에 대한 왕성한 투자가 견인해 2024년 세계 시장을 독점했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 외용약 시장의 변수, 동향, 범위

• 시장 계통의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 외용약 시장 : 투여경로 비즈니스 분석

• 투여 경로별 시장 점유율, 2024년과 2030년
• 투여 경로 부문 대시보드
• 시장 규모와 예측과 동향 분석, 투여 경로별, 2018-2030년
• 경피 약물 전달
• 안과 약물 전달
• 직장내 약물 전달
• 질내 약물 전달
• 비강내 약물 전달

제5장 외용약 시장 : 유형 비즈니스 분석

• 유형별 시장 점유율, 2024년과 2030년
• 유형 부문 대시보드
• 시장 규모와 예측과 동향 분석, 유형별, 2018-2030년
• 반고형 제제
• 액체 제형
• 고형 제제
• 경피 흡수 제품

제6장 외용약 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 재택치료
• 병원 및 클리닉
• 화상 센터
• 기타 시설

제7장 외용약 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 국가별, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 참가자 개요
• 기업의 시장 포지셔닝 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일/상장 기업
  • Bayer AG
  • Cipla
  • GSK plc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Bausch Health Companies Inc.
  • Hisamitsu Pharmaceuticals Co., Inc.
  • Merck KGaA
  • GLENMARK PHARMACEUTICALS LTD.
  • MedPharm Ltd.

JHS

영문 목차

영문목차

Topical Drugs Market Growth & Trends:

The global topical drugs market size is expected to reach USD 269.3 billion by 2030, according to a new report by Grand View Research Inc. The industry is expected to grow at a CAGR of 6.0% from 2025 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights:

• Dermal drug delivery dominated the market and accounted for a share of 54.1% in 2024, fueled by its capacity to offer targeted treatment, user-friendly application, and improved patient compliance.
• Semi-solid formulations led the market with a revenue share of 61.9% in 2024 due to their versatility, ease of use, and effectiveness in delivering active ingredients directly to the skin.
• Hospitals & clinics held the largest revenue share of 38.9% in 2024, driven by the growing prevalence of skin disorders and chronic diseases necessitating professional intervention.
• North America topical drugs market dominated the global market in 2024, driven by a high prevalence of skin disorders, advanced healthcare infrastructure, and robust investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Route of Administration
  • 1.2.2. Type
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Topical Drugs Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Topical Drugs Market: Route of Administration Business Analysis

• 4.1. Route of Administration Market Share, 2024 & 2030
• 4.2. Route of Administration Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
• 4.4. Dermal Drug Delivery
  • 4.4.1. Dermal Drug Delivery Market, 2018 - 2030 (USD Million)
• 4.5. Ophthalmic Drug Delivery
  • 4.5.1. Ophthalmic Drug Delivery Market, 2018 - 2030 (USD Million)
• 4.6. Rectal Drug Delivery
  • 4.6.1. Rectal Drug Delivery Market, 2018 - 2030 (USD Million)
• 4.7. Vaginal Drug Delivery
  • 4.7.1. Vaginal Drug Delivery Market, 2018 - 2030 (USD Million)
• 4.8. Nasal Drug Delivery
  • 4.8.1. Nasal Drug Delivery Market, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Market: Type Business Analysis

• 5.1. Type Market Share, 2024 & 2030
• 5.2. Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Semi-solid Formulations
  • 5.4.1. Semi-solid Formulations Market, 2018 - 2030 (USD Million)
  • 5.4.2. Creams
    • 5.4.2.1. Creams Market, 2018 - 2030 (USD Million)
  • 5.4.3. Ointments
    • 5.4.3.1. Ointments Market, 2018 - 2030 (USD Million)
  • 5.4.4. Lotions
    • 5.4.4.1. Lotions Market, 2018 - 2030 (USD Million)
  • 5.4.5. Gel
    • 5.4.5.1. Gel Market, 2018 - 2030 (USD Million)
  • 5.4.6. Pastes
    • 5.4.6.1. Pastes Market, 2018 - 2030 (USD Million)
• 5.5. Liquid Formulations
  • 5.5.1. Liquid Formulations Market, 2018 - 2030 (USD Million)
  • 5.5.2. Suspensions
    • 5.5.2.1. Suspensions Market, 2018 - 2030 (USD Million)
  • 5.5.3. Solutions
    • 5.5.3.1. Solutions Market, 2018 - 2030 (USD Million)
• 5.6. Solid Formulations
  • 5.6.1. Solid Formulations Market, 2018 - 2030 (USD Million)
  • 5.6.2. Powders
    • 5.6.2.1. Powders Market, 2018 - 2030 (USD Million)
  • 5.6.3. Suppositories
    • 5.6.3.1. Suppositories Market, 2018 - 2030 (USD Million)
• 5.7. Transdermal Products
  • 5.7.1. Transdermal Products Market, 2018 - 2030 (USD Million)
  • 5.7.2. Transdermal Patches
    • 5.7.2.1. Transdermal Patches Market, 2018 - 2030 (USD Million)
  • 5.7.3. Transdermal Semi-Solids
    • 5.7.3.1. Transdermal Semi-Solids Market, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Home Care Settings
  • 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
• 6.5. Hospitals & Clinics
  • 6.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 6.6. Burn Centers
  • 6.6.1. Burn Centers Market, 2018 - 2030 (USD Million)
• 6.7. Other Facilities
  • 6.7.1. Other Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Bayer AG
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Cipla
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. GSK plc
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Johnson & Johnson Services, Inc.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Novartis AG
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Bausch Health Companies Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Hisamitsu Pharmaceuticals Co., Inc.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Merck KGaA
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. GLENMARK PHARMACEUTICALS LTD.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. MedPharm Ltd.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives

관련자료